Table 3. Results from crude and adjusted analysis of change in fentanyl dose, ESAS QoL-score and infections (% days with antibiotics) compared to baseline in vitamin D treated and untreated patient after 3 month.
Figures show mean value (95% CI).
3 months (n = 26) | ||||
---|---|---|---|---|
Outcome | Mean change from baseline | Crude mean difference in change (95% CI) | Adjusted mean difference in change (95% CI) | |
Fentanyl | Treated | -6 μg/h | -91 μg/h (-140 –(-56)) | -120 μg/h (-185 –(-49)) |
Untreated | 85 μg/h | |||
ESAS | Treated | -1.3 | -1.6 (-3.1–0) | -2.0 (-4.4–0.72) |
Untreated | 0.3 | |||
Infections | Treated | -13% | -26% (-41%–(-12%)) | -29% (-49%–(-11%)) |
Untreated | 13% |